• Adrian Simpson, United States says, "If you are looking for a fair deal on medical supplies, IDM is something I would seriously recommend. Am hooked for life."
  • Craig, United States says, "Seemed easy to purchase, reasonable prices. Good customer service when I used it."
  • Brian Pavey, United States says, "IDM makes online shopping a pleasure. Shopping is so simple that you just breeze through it."
  • Harry Mason, United States says, "I have to admit am a bit of a lazy bloke when it comes to ordering online .And IDM pampers me to the hit as it's so simple to order."
  • John Hanks, United States says, "I was a sceptic until my first order. After, I received my first package, I turned believer. Now, it’s been 3 years since I have been ordering from IDM."
  • Natalie Wallace, United States says, "I was apprehensive about how my doubts would be addressed but what the heck,I went ahead and placed my order. Customer service was patient and helped me out."
  • Mark Penning, United States says, "Happy I got my package just in time for my vacation. Needless to say, it made my holiday a wonderfully satisfying experience."
  • Ask our pharmacist, if you have any questions related to your medications
    Click to find International Shipping charges at our pharmacy.
    Shop & Earn @ InternationalDrugMart
    Easy and secure shopping @ InternationalDrugMart.com.
    Get your instant Coupon now!
    You can find the latest happening of our pharmacy
    Follow us on Twitter

      Pharma Sector to Top Rs 60,000 cr by '08

      Posted AtRediff.com

      Industry body Assocham on Tuesday said the Indian pharma industry would grow at 11 per cent to touch Rs 60,000 crore (Rs 600 billion) in 2007-08 from Rs 39,000 crore (Rs 390 billion) in 2003-04, when drugs worth $65 billion would go off patent.
      Pharmaceutical exports from India would grow at 18 per cent to touch volume of Rs 30,000 crore (Rs 300 billion) in 2007-08 from Rs 15,500 crore ( Rs 155 billion) during 2003-04, according to a study released by Assocham in New Delhi on Tuesday.

      "India with low production cost of generic drugs has an edge over its competitors in foreign markets. Several products in the developed markets are supposed to lose patent protection in coming years, which would benefit Indian products," Assocham president M K Sanghi said.

      The study also points out that globally drugs worth $40 billion would go off patent this year and another $70 billion dollar would go off patent in 2008.

      Indian pharma companies would then raise their stake in the world market to 30 per cent, it said. The study also observed that migration to the new product regime would benefit the domestic pharma industry in the long run. It would also see innovative products being launched in the market.

      Indian companies could leverage their strength in terms of low cost of production and availability of quality manpower as domestic production cost was 50 per cent less as compared to developed countries, it said.

      September 20, 2005


      Share this Article!

    Back to top^